BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Press Releases

  Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics

  February 2, 2026

   · 

  4 min read
• Press Releases

  Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate

  February 2, 2026

   · 

  3 min read
• Press Releases

  Iridex Announces Plans to Relocate Headquarters

  February 2, 2026

   · 

  3 min read
• Press Releases

  Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth

  February 2, 2026

   · 

  9 min read
• Press Releases

  Agomab Announces Launch of Initial Public Offering

  February 2, 2026

   · 

  4 min read
• Press Releases

  AlzeCure Pharma Selected to Present at the Bio-Neuroscience conference in Amsterdam

  February 2, 2026

   · 

  3 min read
• Press Releases

  Zevra Therapeutics to Ring Nasdaq Stock Market Opening Bell on Monday, February 9, 2026

  February 2, 2026

   · 

  1 min read
• Press Releases

  Groundbreaking therapy for advanced heart failure

  February 2, 2026

   · 

  3 min read
• Press Releases

  Palvella Therapeutics Announces Scientific Publication in Clinical and Experimental Dermatology Highlighting a Systematic Review of Real-World Statin Evidence and Persistent Treatment Gaps Resulting from the Lack of FDA-Approved Therapies in Porokeratosis

  February 2, 2026

   · 

  8 min read
• Press Releases

  SanegeneBio Announces RNAi Global Licensing Collaboration with Genentech

  February 2, 2026

   · 

  2 min read